Clinical Trial Update: Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients. [Phase 1, Phase 2]

View source ↗

Summary

A randomized, placebo/active crossover dose-ranging study in asthma patients (Phase 1/2) sponsored by Amphastar Pharmaceuticals was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 1, Phase 2 | Status: TERMINATED